Ethocle Reports has published its latest Market Research Report on Seborrhea – Pipeline Review, H1 2017. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase II, Preclinical and Discovery stages are 1, 2, 2 and 2 respectively. Browse market data tables and figures.
Published On: 15-Mar-2017 | Pages: 39
Pharmaceutical and Healthcare disease pipeline guide Seborrhea – Pipeline Review, H1 2017, provides an overview of the Seborrhea (Dermatology) pipeline landscape.
Seborrhea is form of skin eczema that mainly affects scalp, ears, face, chest, and folds of skin. Symptoms include skin flakes, red skin, itching and skin lesions. Risk factors include stress or fatigue, skin acne and obesity. Treatment includes antifungal medications.
Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Seborrhea – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Seborrhea (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Seborrhea (Dermatology).
- The pipeline guide reviews pipeline therapeutics for Seborrhea (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Seborrhea (Dermatology).
- Classify potential new clients or partners in the target demographic.
Table of Contents
Global Markets Direct Report Coverage
Seborrhea – Overview
Seborrhea – Therapeutics Development
Products under Development by Companies
Seborrhea – Therapeutics Assessment
Assessment by Target
Seborrhea – Companies Involved in Therapeutics Development
Aclaris Therapeutics Inc
Seborrhea – Drug Profiles
hydrogen peroxide – Drug Profile
Mechanism Of Action